ArticleFrontiers in oncology2020

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy.

Shuai Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.